Weight loss drugs don’t increase the risk of pancreatitis or adverse cardiac events in patients with high triglycerides
Reports and Proceedings
Updates every hour. Last Updated: 22-Dec-2025 15:12 ET (22-Dec-2025 20:12 GMT/UTC)
In a major new study, researchers from Intermountain Health in Salt Lake City have found that weight loss drugs used by patients who have high triglycerides do not increase their risk of pancreatitis or adverse cardiac events.
Opening all blocked arteries with stents in patients with a heart attack, known as complete revascularization, reduces the risk of death from cardiovascular causes, death from any cause and future heart attacks compared with opening only culprit artery causing the heart attack according to a new, large international study led by researchers at the Population Health Research Institute (PHRI), a joint organization of McMaster University and Hamilton Health Sciences.
A new study from researchers at Intermountain Health reveals that hypertensive disorders of pregnancy (HDP) significantly increase the risk of cardiovascular complications — including heart attack, stroke, heart failure, and death — within five years of giving birth.
A tailored approach of vitamin D3 supplementation in patients who have suffered a heart attack significantly reduces their risk of a second heart attack, a new study from heart researchers at Intermountain Health in Salt Lake City finds.
Researchers have developed miniature magnetic robots that mimic fish behavior, working together as coordinated swarms to deliver drugs precisely and efficiently to tissue. The breakthrough could transform treatment of conditions where individual tiny robots lack sufficient coverage area for effective therapy.
A large-scale genomic study by researchers at Central South University and King’s College London reveals that rare and common genetic risks interact antagnistically to maintain healthy telomere length — a key indicator of cellular aging. Analyzing genomic data from nearly 380,000 UK Biobank participants, the team discovered a built-in genetic balance that prevents telomeres from becoming too short or excessively long, highlighting a previously unseen genetic mechanism underlying telomere stability.